Kroger (KR): FY24 Q3 earnings call, Dec 5, 2024
No Kalshi or Polymarket word markets were listed for Kroger’s Dec 5, 2024 earnings call (FY24 Q3). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
5 matches for “GLP-1”; 5 quoted, at least 25 words apart.
…quarter were well ahead of last year, led by growth in both GLP-1s and vaccines. Our strong growth in vaccines reflect patient trust in Kroger…
…versus a year ago. These helped offset the product mix pressures from GLP-1s. Our vaccine efforts are leading to new patient scripts, which is important…
…long-term algorithm in 2025? This year, there’s been a contribution from the GLP-1 drug, some storm-related spending, perhaps those won’t be as meaningful contributors next…
…especially the storing that you hit on earlier as well. You mentioned GLP-1 and that certainly has been part of this year, but as we…
…I think we’ll still see -- expect to see growth in the GLP-1 space as well for the -- at least near future, foreseeable future.
Agents: this page as TSV at /api/v1/appearances/kroger:2024-12-05:earnings_call · words: /api/v1/brief?appearance=kroger:2024-12-05:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP